Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Oriol R. Gutierrez Jr. discusses the challenges of weight gain while living with HIV with Lepena Reid and Liz Highleyman.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
The antiretroviral drug class includes bictegravir, dolutegravir, elvitegravir and raltegravir.
A study looked at the fat composition of people who switched their antiretrovirals to include an integrase inhibitor.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Aging with HIV won’t slow down Robert Gillum.
A healthy diet and exercise are key to controlling excess weight.
Some HIV meds are linked to weight gain, but we don’t yet know why.
HIV advocate Lepena Reid confronts weight gain.
Overweight and obesity are linked to a host of health problems.
The reasons for gaining weight aren’t always clear.
More studies link dolutegravir and other drugs to weight gain among people with HIV.
Abnormal body fat distribution includes visceral fat and a hard belly.
This special issue of POZ Focus is dedicated to understanding lipodystrophy among people living with HIV.
The effect is greater for women, and it could have a detrimental effect on pregnancy outcomes at the population level.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.